The RANK/RANKL/osteoprotegerin system in rheumatoid arthritis: New insights from animal models

This publication has 70 references indexed in Scilit:

• Synovial fibroblasts promote osteoclast formation by RANKL in a novel model of spontaneous erosive arthritis
  Arthritis & Rheumatism, 2005
• Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast
  Published by Elsevier ,2005
• IL-4 suppresses osteoclast development and mature osteoclast function by a STAT6-dependent mechanism: irreversible inhibition of the differentiation program activated by RANKL
  Blood, 2003
• RANKL and RANK as novel therapeutic targets for arthritis
  Current Opinion in Rheumatology, 2003
• Osteoclast differentiation and activation
  Nature, 2003
• High levels of osteoprotegerin and soluble receptor activator of nuclear factor κB ligand in serum of rheumatoid arthritis patients and their normalization after anti–tumor necrosis factor α treatment
  Arthritis & Rheumatism, 2002
• Trance, a Tumor Necrosis Factor Family Member, Enhances the Longevity and Adjuvant Properties of Dendritic Cells in Vivo
  The Journal of Experimental Medicine, 2000
• Involvement of receptor activator of nuclear factor κB ligand/osteoclast differentiation factor in osteoclastogenesis from synoviocytes in rheumatoid arthritis
  Arthritis & Rheumatism, 2000
• IL-17 in synovial fluids from patients with rheumatoid arthritis is a potent stimulator of osteoclastogenesis
  Journal of Clinical Investigation, 1999
• A New Mechanism of Bone Destruction in Rheumatoid Arthritis: Synovial Fibroblasts Induce Osteoclastogenesis
  Biochemical and Biophysical Research Communications, 1997